Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus

Purposes. To investigate the possible changes in B cell subsets and in B cell expression patterns of lipid rafts (LRs) and F-actin in patients with SLE and whether leflunomide treatment may have effect on these changes. Methods. The B cell subsets and LRs expression were determined by flow cytometry...

Full description

Saved in:
Bibliographic Details
Main Authors: Guang Fu Dong, Xiao Zhang, De Ning He, Ling Li, Guang Feng Zhang
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2015/832916
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546114315747328
author Guang Fu Dong
Xiao Zhang
De Ning He
Ling Li
Guang Feng Zhang
author_facet Guang Fu Dong
Xiao Zhang
De Ning He
Ling Li
Guang Feng Zhang
author_sort Guang Fu Dong
collection DOAJ
description Purposes. To investigate the possible changes in B cell subsets and in B cell expression patterns of lipid rafts (LRs) and F-actin in patients with SLE and whether leflunomide treatment may have effect on these changes. Methods. The B cell subsets and LRs expression were determined by flow cytometry and confocal microscopy, and F-actin expression was examined by confocal microscopy. Results. CD27+IgD+ B cell subsets were significantly decreased while CD38+CD95+ B cell subsets increased in SLE patients. The LRs levels of B cells were remarkably increased and positively correlated with SLEDAI and anti-dsDNA titer in SLE patients. The expression level of LRs was significantly higher in CD38+ B cells than CD38− B cells and negatively correlated with C3 levels. The increased expression of LRs was associated with reduced expression of F-actin in the B cells from active SLE patients. Furthermore, in vitro treatment of the cells with A771726 reduced the expression level of LRs, attenuated the overaggregation of LRs, and normalized the distribution of F-actin. Conclusions. There were abnormalities in B cell subsets and LRs and F-actin expression of B cell from SLE patients. Modulation of B cell expression of LRs and F-actin by LEF could be a potential therapeutic target for SLE.
format Article
id doaj-art-1cc7cb5659074d19b8c4d3540e888211
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-1cc7cb5659074d19b8c4d3540e8882112025-02-03T07:23:49ZengWileyJournal of Immunology Research2314-88612314-71562015-01-01201510.1155/2015/832916832916Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus ErythematosusGuang Fu Dong0Xiao Zhang1De Ning He2Ling Li3Guang Feng Zhang4Department of Rheumatology and Immunology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Rheumatology and Immunology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Rheumatology and Immunology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Rheumatology and Immunology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Rheumatology and Immunology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaPurposes. To investigate the possible changes in B cell subsets and in B cell expression patterns of lipid rafts (LRs) and F-actin in patients with SLE and whether leflunomide treatment may have effect on these changes. Methods. The B cell subsets and LRs expression were determined by flow cytometry and confocal microscopy, and F-actin expression was examined by confocal microscopy. Results. CD27+IgD+ B cell subsets were significantly decreased while CD38+CD95+ B cell subsets increased in SLE patients. The LRs levels of B cells were remarkably increased and positively correlated with SLEDAI and anti-dsDNA titer in SLE patients. The expression level of LRs was significantly higher in CD38+ B cells than CD38− B cells and negatively correlated with C3 levels. The increased expression of LRs was associated with reduced expression of F-actin in the B cells from active SLE patients. Furthermore, in vitro treatment of the cells with A771726 reduced the expression level of LRs, attenuated the overaggregation of LRs, and normalized the distribution of F-actin. Conclusions. There were abnormalities in B cell subsets and LRs and F-actin expression of B cell from SLE patients. Modulation of B cell expression of LRs and F-actin by LEF could be a potential therapeutic target for SLE.http://dx.doi.org/10.1155/2015/832916
spellingShingle Guang Fu Dong
Xiao Zhang
De Ning He
Ling Li
Guang Feng Zhang
Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus
Journal of Immunology Research
title Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus
title_full Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus
title_fullStr Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus
title_full_unstemmed Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus
title_short Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus
title_sort effect of leflunomide on the abnormal expression of lipid rafts and f actin in b lymphocytes from patients with systemic lupus erythematosus
url http://dx.doi.org/10.1155/2015/832916
work_keys_str_mv AT guangfudong effectofleflunomideontheabnormalexpressionoflipidraftsandfactininblymphocytesfrompatientswithsystemiclupuserythematosus
AT xiaozhang effectofleflunomideontheabnormalexpressionoflipidraftsandfactininblymphocytesfrompatientswithsystemiclupuserythematosus
AT deninghe effectofleflunomideontheabnormalexpressionoflipidraftsandfactininblymphocytesfrompatientswithsystemiclupuserythematosus
AT lingli effectofleflunomideontheabnormalexpressionoflipidraftsandfactininblymphocytesfrompatientswithsystemiclupuserythematosus
AT guangfengzhang effectofleflunomideontheabnormalexpressionoflipidraftsandfactininblymphocytesfrompatientswithsystemiclupuserythematosus